_id
69130113ccc777a4e85d7906
Ticker
IMAB
Name
I-Mab
Exchange
NASDAQ
Address
2440 Research Boulevard, Rockville, MD, United States, 20850
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.i-mabbiopharma.com
Description
I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.
Last Close
3.88
Volume
266377
Current Price
3.84
Change
-0.02
Last Updated
2025-12-01T09:17:22.368Z
Image
data:image/webp;base64,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
Ipo Date
2020-01-17T00:00:00.000Z
Market Cap
533681856
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.6
Target Price
8.6
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
7114000
Operating Income
-7114000
Interest Expense
-
Pretax Income
-5504000
Net Income
-5504000
Eps
-0.06736901723132752
Dividends Per Share
-
Shares Outstanding
115266053
Income Tax Expense
-
EBITDA
-7114000
Operating Margin
-
Total Other Income Expense Net
1610000
Cash
165404000
Short Term Investments
210000
Receivables
2026000
Inventories
-
Total Current Assets
167640000
Property Plant Equipment
3381000
Total Assets
206708000
Payables
-
Short Term Debt
853000
Long Term Debt
-
Total Liabilities
9975000
Equity
196733000
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
PE
-
PB
1.5946751367589576
ROE
-2.79770043663239
ROA
-2.662693267798053
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
4
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
7114000
Quarters > 0 > income Statement > operating Income
-7114000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-5504000
Quarters > 0 > income Statement > net Income
-5504000
Quarters > 0 > income Statement > eps
-0.06736901723132752
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
81699277
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7114000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1610000
Quarters > 0 > balance Sheet > cash
165404000
Quarters > 0 > balance Sheet > short Term Investments
210000
Quarters > 0 > balance Sheet > receivables
2026000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
167640000
Quarters > 0 > balance Sheet > property Plant Equipment
3381000
Quarters > 0 > balance Sheet > total Assets
206708000
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
853000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
9975000
Quarters > 0 > balance Sheet > equity
196733000
Quarters > 0 > cash Flow > net Income
-13267542
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > ratios > PE
-0.06736901723132752
Quarters > 0 > ratios > PB
1.5946751367589576
Quarters > 0 > ratios > ROE
-2.79770043663239
Quarters > 0 > ratios > ROA
-2.662693267798053
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
5266000
Quarters > 1 > income Statement > operating Income
-5266000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3150000
Quarters > 1 > income Statement > net Income
-3150000
Quarters > 1 > income Statement > eps
-0.03860304809177535
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
81599774
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-5266000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2116000
Quarters > 1 > balance Sheet > cash
53597000
Quarters > 1 > balance Sheet > short Term Investments
115025000
Quarters > 1 > balance Sheet > receivables
4611000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
173233000
Quarters > 1 > balance Sheet > property Plant Equipment
3592000
Quarters > 1 > balance Sheet > total Assets
208941000
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
835000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10600000
Quarters > 1 > balance Sheet > equity
198341000
Quarters > 1 > cash Flow > net Income
-22868685
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > ratios > PE
-0.03860304809177535
Quarters > 1 > ratios > PB
1.5798202699391453
Quarters > 1 > ratios > ROE
-1.5881739025214152
Quarters > 1 > ratios > ROA
-1.507602624664379
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
12098000
Quarters > 2 > income Statement > operating Income
-12098000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-10844000
Quarters > 2 > income Statement > net Income
-9062000
Quarters > 2 > income Statement > eps
-0.048342914827567376
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
187452495
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-943000
Quarters > 2 > balance Sheet > cash
68263000
Quarters > 2 > balance Sheet > short Term Investments
105135000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
176693000
Quarters > 2 > balance Sheet > property Plant Equipment
3798000
Quarters > 2 > balance Sheet > total Assets
212680000
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
11520000
Quarters > 2 > balance Sheet > equity
201160000
Quarters > 2 > cash Flow > net Income
-9062000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > ratios > PE
-0.048342914827567376
Quarters > 2 > ratios > PB
3.5783335692980716
Quarters > 2 > ratios > ROE
-4.504871743885464
Quarters > 2 > ratios > ROA
-4.260861388000752
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
12412000
Quarters > 3 > income Statement > operating Income
-12412000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-20491000
Quarters > 3 > income Statement > net Income
-20491000
Quarters > 3 > income Statement > eps
-0.2514361376690097
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
81495843
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-6422107
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-8079000
Quarters > 3 > balance Sheet > cash
79327000
Quarters > 3 > balance Sheet > short Term Investments
105064000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
188211000
Quarters > 3 > balance Sheet > property Plant Equipment
3691000
Quarters > 3 > balance Sheet > total Assets
232682000
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
753000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
14799000
Quarters > 3 > balance Sheet > equity
217883000
Quarters > 3 > cash Flow > net Income
-143797641
Quarters > 3 > cash Flow > depreciation
5989893
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > ratios > PE
-0.2514361376690097
Quarters > 3 > ratios > PB
1.43629396107085
Quarters > 3 > ratios > ROE
-9.404588701275456
Quarters > 3 > ratios > ROA
-8.806439690220987
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
375358000
Annuals > 0 > income Statement > operating Income
-375358000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-362731000
Annuals > 0 > income Statement > net Income
-162257000
Annuals > 0 > income Statement > eps
-1.998581382529021
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
81186086
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-373453000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
12627000
Annuals > 0 > balance Sheet > cash
68263000
Annuals > 0 > balance Sheet > short Term Investments
105135000
Annuals > 0 > balance Sheet > receivables
1172000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
176693000
Annuals > 0 > balance Sheet > property Plant Equipment
3798000
Annuals > 0 > balance Sheet > total Assets
212680000
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
816000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
11520000
Annuals > 0 > balance Sheet > equity
201160000
Annuals > 0 > cash Flow > net Income
-49696000
Annuals > 0 > cash Flow > depreciation
978000
Annuals > 0 > cash Flow > change In Working Capital
-2811000
Annuals > 0 > cash Flow > cash From Operations
-52669000
Annuals > 0 > cash Flow > capital Expenditures
48000
Annuals > 0 > cash Flow > cash From Investing
-136015000
Annuals > 0 > cash Flow > cash From Financing
-335000
Annuals > 0 > cash Flow > net Change In Cash
-242404000
Annuals > 0 > ratios > PE
-1.998581382529021
Annuals > 0 > ratios > PB
1.5497841034002782
Annuals > 0 > ratios > ROE
-80.66066812487573
Annuals > 0 > ratios > ROA
-76.2916118111717
Annuals > 0 > ratios > FCF
-52717000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
4485809
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
4485809
Annuals > 1 > income Statement > operating Expenses
515647809
Annuals > 1 > income Statement > operating Income
-511162000
Annuals > 1 > income Statement > interest Expense
101854
Annuals > 1 > income Statement > pretax Income
-1465693999
Annuals > 1 > income Statement > net Income
-1465694000
Annuals > 1 > income Statement > eps
-17.610638565786225
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
83227760
Annuals > 1 > income Statement > income Tax Expense
-1258926232
Annuals > 1 > income Statement > EBITDA
-344250000
Annuals > 1 > income Statement > operating Margin
-11395.090606844831
Annuals > 1 > income Statement > total Other Income Expense Net
-954531999
Annuals > 1 > balance Sheet > cash
2141445000
Annuals > 1 > balance Sheet > short Term Investments
20221000
Annuals > 1 > balance Sheet > receivables
1833000
Annuals > 1 > balance Sheet > inventories
28955000
Annuals > 1 > balance Sheet > total Current Assets
2336669000
Annuals > 1 > balance Sheet > property Plant Equipment
5554000
Annuals > 1 > balance Sheet > total Assets
2612967000
Annuals > 1 > balance Sheet > payables
-33104000
Annuals > 1 > balance Sheet > short Term Debt
51860000
Annuals > 1 > balance Sheet > long Term Debt
58913000
Annuals > 1 > balance Sheet > total Liabilities
894811000
Annuals > 1 > balance Sheet > equity
1718156000
Annuals > 1 > cash Flow > net Income
-206767767
Annuals > 1 > cash Flow > depreciation
7436306
Annuals > 1 > cash Flow > change In Working Capital
-37122000
Annuals > 1 > cash Flow > cash From Operations
-1304950000
Annuals > 1 > cash Flow > capital Expenditures
164000
Annuals > 1 > cash Flow > cash From Investing
102515000
Annuals > 1 > cash Flow > cash From Financing
7572000
Annuals > 1 > cash Flow > net Change In Cash
-1110411000
Annuals > 1 > ratios > PE
-17.610638565786225
Annuals > 1 > ratios > PB
0.18601023329662733
Annuals > 1 > ratios > ROE
-85.30622364907494
Annuals > 1 > ratios > ROA
-56.09309264143022
Annuals > 1 > ratios > FCF
-1305114000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-290.9428377356236
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
-10697247
Annuals > 2 > income Statement > cost Of Revenue
27237000
Annuals > 2 > income Statement > gross Profit
-248800000
Annuals > 2 > income Statement > operating Expenses
355380753
Annuals > 2 > income Statement > operating Income
-366078000
Annuals > 2 > income Statement > interest Expense
1304
Annuals > 2 > income Statement > pretax Income
-973166000
Annuals > 2 > income Statement > net Income
-2507317000
Annuals > 2 > income Statement > eps
-30.385749767745644
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
82516213
Annuals > 2 > income Statement > income Tax Expense
697000
Annuals > 2 > income Statement > EBITDA
-51230000
Annuals > 2 > income Statement > operating Margin
3422.1702088397137
Annuals > 2 > income Statement > total Other Income Expense Net
-607088000
Annuals > 2 > balance Sheet > cash
3214005000
Annuals > 2 > balance Sheet > short Term Investments
235429000
Annuals > 2 > balance Sheet > receivables
4811502
Annuals > 2 > balance Sheet > inventories
-80278000
Annuals > 2 > balance Sheet > total Current Assets
3626476000
Annuals > 2 > balance Sheet > property Plant Equipment
123966000
Annuals > 2 > balance Sheet > total Assets
4073665000
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
6220486
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1065339000
Annuals > 2 > balance Sheet > equity
3008326000
Annuals > 2 > cash Flow > net Income
-2507317000
Annuals > 2 > cash Flow > depreciation
63816000
Annuals > 2 > cash Flow > change In Working Capital
552064000
Annuals > 2 > cash Flow > cash From Operations
-1102805000
Annuals > 2 > cash Flow > capital Expenditures
45830000
Annuals > 2 > cash Flow > cash From Investing
458382000
Annuals > 2 > cash Flow > cash From Financing
42357000
Annuals > 2 > cash Flow > net Change In Cash
-212863000
Annuals > 2 > ratios > PE
-30.385749767745644
Annuals > 2 > ratios > PB
0.10532843113412575
Annuals > 2 > ratios > ROE
-83.34592062163476
Annuals > 2 > ratios > ROA
-61.54941557540937
Annuals > 2 > ratios > FCF
-1148635000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
107.3766923396272
Annuals > 2 > health Score
51
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
88026000
Annuals > 3 > income Statement > cost Of Revenue
46432000
Annuals > 3 > income Statement > gross Profit
41594000
Annuals > 3 > income Statement > operating Expenses
2112900000
Annuals > 3 > income Statement > operating Income
-2071307000
Annuals > 3 > income Statement > interest Expense
2991000
Annuals > 3 > income Statement > pretax Income
-2332035814
Annuals > 3 > income Statement > net Income
-2331541000
Annuals > 3 > income Statement > eps
-30.694492041024603
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
75959589
Annuals > 3 > income Statement > income Tax Expense
-494814
Annuals > 3 > income Statement > EBITDA
-2057531000
Annuals > 3 > income Statement > operating Margin
-2353.062731465703
Annuals > 3 > income Statement > total Other Income Expense Net
-260728814
Annuals > 3 > balance Sheet > cash
3523632000
Annuals > 3 > balance Sheet > short Term Investments
753164000
Annuals > 3 > balance Sheet > receivables
60952291
Annuals > 3 > balance Sheet > inventories
4273073
Annuals > 3 > balance Sheet > total Current Assets
4781718000
Annuals > 3 > balance Sheet > property Plant Equipment
158497000
Annuals > 3 > balance Sheet > total Assets
5629431000
Annuals > 3 > balance Sheet > payables
-2369000
Annuals > 3 > balance Sheet > short Term Debt
30669000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1041635000
Annuals > 3 > balance Sheet > equity
4587796000
Annuals > 3 > cash Flow > net Income
-2331541000
Annuals > 3 > cash Flow > depreciation
34136000
Annuals > 3 > cash Flow > change In Working Capital
394520000
Annuals > 3 > cash Flow > cash From Operations
-973093000
Annuals > 3 > cash Flow > capital Expenditures
29932000
Annuals > 3 > cash Flow > cash From Investing
-727206000
Annuals > 3 > cash Flow > cash From Financing
593924000
Annuals > 3 > cash Flow > net Change In Cash
-1235146000
Annuals > 3 > ratios > PE
-30.694492041024603
Annuals > 3 > ratios > PB
0.06357842017386998
Annuals > 3 > ratios > ROE
-50.82050291686902
Annuals > 3 > ratios > ROA
-41.416992232429884
Annuals > 3 > ratios > FCF
-1003025000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-11.394644764046985
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.06736901723132752
Valuation > metrics > PB
1.5946751367589576
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-2.79770043663239
Profitability > metrics > ROA
-3.2832259603913143
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.05070323738264552
Risk > metrics > Interest Coverage
-4.418633540372671
Risk > final Score
42
Risk > verdict
High
Liquidity > metrics > Current Ratio
196.52989449003516
Liquidity > metrics > Quick Ratio
196.52989449003516
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
44.216664307019286
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
50
Prev Risks > 1
9
Prev Risks > 2
56
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2025-12-14T00:39:54.996Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-01
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.13
Earnings History > 0 > eps Difference
0.13
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-10-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.07
Earnings History > 1 > eps Estimate
-0.04
Earnings History > 1 > eps Difference
-0.03
Earnings History > 1 > surprise Percent
-75
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-20
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.07
Earnings History > 2 > eps Estimate
-0.04
Earnings History > 2 > eps Difference
-0.03
Earnings History > 2 > surprise Percent
-75
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-03
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.055
Earnings History > 3 > eps Estimate
-0.06
Earnings History > 3 > eps Difference
0.005
Earnings History > 3 > surprise Percent
8.3333
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-12
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
CNY
Earnings History > 4 > eps Actual
-0.06
Earnings History > 4 > eps Estimate
-0.05
Earnings History > 4 > eps Difference
-0.01
Earnings History > 4 > surprise Percent
-20
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-14
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.11
Earnings History > 5 > eps Estimate
-0.07
Earnings History > 5 > eps Difference
-0.04
Earnings History > 5 > surprise Percent
-57.1429
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-28
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.09
Earnings History > 6 > eps Estimate
-0.31
Earnings History > 6 > eps Difference
0.22
Earnings History > 6 > surprise Percent
70.9677
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-06-05
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
CNY
Earnings History > 7 > eps Actual
-0.2196
Earnings History > 7 > eps Estimate
-0.1231
Earnings History > 7 > eps Difference
-0.0965
Earnings History > 7 > surprise Percent
-78.3916
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-14
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.4808
Earnings History > 8 > eps Estimate
-0.48
Earnings History > 8 > eps Difference
-0.0008
Earnings History > 8 > surprise Percent
-0.1667
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-29
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CNY
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
-0.13
Earnings History > 9 > eps Difference
0.13
Earnings History > 9 > surprise Percent
100
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-17
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
CNY
Earnings History > 10 > eps Actual
-0.5564
Earnings History > 10 > eps Estimate
-0.78
Earnings History > 10 > eps Difference
0.2236
Earnings History > 10 > surprise Percent
28.6667
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-31
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
-0.1397
Earnings History > 11 > eps Estimate
-0.14
Earnings History > 11 > eps Difference
0.0003
Earnings History > 11 > surprise Percent
0.2143
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-31
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
CNY
Earnings History > 12 > eps Actual
-1.01
Earnings History > 12 > eps Estimate
-0.49
Earnings History > 12 > eps Difference
-0.52
Earnings History > 12 > surprise Percent
-106.1224
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-30
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
-0.4644
Earnings History > 13 > eps Estimate
-0.46
Earnings History > 13 > eps Difference
-0.0044
Earnings History > 13 > surprise Percent
-0.9565
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-30
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
CNY
Earnings History > 14 > eps Actual
-0.99
Earnings History > 14 > eps Estimate
-1.24
Earnings History > 14 > eps Difference
0.25
Earnings History > 14 > surprise Percent
20.1613
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-06-01
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
-0.4538
Earnings History > 15 > eps Estimate
-0.45
Earnings History > 15 > eps Difference
-0.0038
Earnings History > 15 > surprise Percent
-0.8444
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-29
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
CNY
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
-0.48
Earnings History > 16 > eps Difference
0.48
Earnings History > 16 > surprise Percent
100
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-12-01
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
-0.239
Earnings History > 17 > eps Estimate
-0.24
Earnings History > 17 > eps Difference
0.001
Earnings History > 17 > surprise Percent
0.4167
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-31
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
-0.99
Earnings History > 18 > eps Estimate
-0.99
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-02
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
CNY
Earnings History > 19 > eps Actual
-0.362
Earnings History > 19 > eps Estimate
-0.36
Earnings History > 19 > eps Difference
-0.002
Earnings History > 19 > surprise Percent
-0.5556
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-29
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
CNY
Earnings History > 20 > eps Actual
0.8548
Earnings History > 20 > eps Estimate
0.91
Earnings History > 20 > eps Difference
-0.0552
Earnings History > 20 > surprise Percent
-6.0659
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-12-02
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
CNY
Earnings History > 21 > eps Actual
0.6973
Earnings History > 21 > eps Estimate
0.7
Earnings History > 21 > eps Difference
-0.0027
Earnings History > 21 > surprise Percent
-0.3857
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-08-31
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
CNY
Earnings History > 22 > eps Actual
-0.53
Earnings History > 22 > eps Estimate
-0.53
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWill IMAB stock attract more institutional investors - July 2025 Weekly Recap & Real-Time Market Sentiment Reports moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
STRONG BUY
Target Price:
$8.6
Analyst Picks
Strong Buy
3
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 13.08% of the total shares of I-Mab
1.
Hillhouse Capital Advisors, Ltd.(7.3237%)
since
2025/06/30
2.
Candriam Luxembourg S.C.A.(1.3869%)
since
2025/06/30
3.
Belfius Equities Cure C Cap(1.3869%)
since
2025/08/31
4.
SG Americas Securities, LLC(1.0732%)
since
2025/06/30
5.
Two Sigma Advisers, LLC(0.2564%)
since
2025/06/30
6.
UBS Group AG(0.2264%)
since
2025/06/30
7.
Aberdeen Group PLC(0.1671%)
since
2025/06/30
8.
BNP Paribas Arbitrage, SA(0.1499%)
since
2025/06/30
9.
Two Sigma Investments LLC(0.1387%)
since
2025/06/30
10.
Ariose Capital Management Ltd(0.1181%)
since
2025/06/30
11.
Alberta Investment Management Corp(0.0915%)
since
2025/06/30
12.
Renaissance Technologies Corp(0.078%)
since
2025/06/30
13.
Dimensional Fund Advisors, Inc.(0.0715%)
since
2025/06/30
14.
Morgan Stanley - Brokerage Accounts(0.0714%)
since
2025/06/30
15.
Geode Capital Management, LLC(0.0668%)
since
2025/06/30
16.
Fidelity Nasdaq Composite Index(0.0668%)
since
2025/07/31
17.
abrdn Healthcare Opportunities(0.0536%)
since
2025/07/31
18.
Susquehanna International Group, LLP(0.046%)
since
2025/06/30
19.
Change Path, LLC(0.0458%)
since
2025/06/30
20.
Barclays PLC(0.0372%)
since
2025/06/30
21.
Mariner Wealth Advisors LLC(0.0352%)
since
2025/06/30
22.
Connor Clark & Lunn Inv Mgmt Ltd(0.034%)
since
2025/06/30
23.
Dimensional Emerg Mkt Trgtd Val USD Acc(0.0309%)
since
2025/07/31
24.
HRT FINANCIAL LLC(0.0307%)
since
2025/06/30
25.
DFA Emerging Markets Social Core Port(0.0232%)
since
2025/07/31
26.
DFA Emerging Markets Core Equity 2 I(0.0199%)
since
2025/07/31
27.
DFA Em Mkts Sustnby Cor 1 Instl(0.0114%)
since
2025/07/31
28.
ActivePassive International Equity ETF(0.0099%)
since
2025/08/29
29.
Blackstone Alternative Multi-Strategy I(0.0098%)
since
2024/12/31
30.
Dimensional World Equity GBP Acc(0.0073%)
since
2025/07/31
31.
DFA World ex US Core Equity Instl(0.0055%)
since
2025/07/31
32.
Avantis Emerging Markets Eq ETF USD Acc(0.0019%)
since
2025/08/29
33.
Dimensional World Allc 60/40 GBP Acc(0.0018%)
since
2025/07/31
34.
Dimensional EM Cor Eq LC ESG Sc USD A(0.0017%)
since
2025/07/31
35.
Eurizon Equity Emerging Mkts LTE Z Acc(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
-0.13
Date
2025-09-30
EPS Actual
-0.07
EPS Estimate
-0.04
EPS Difference
-0.03
Surprise Percent
-75%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.